These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 823561)

  • 1. Development of tolerance to the antinociceptive effect of mescaline intraventricularly administered to rabbits.
    Ferri S; Santagostino A; Braga PC
    Psychopharmacology (Berl); 1976 Jun; 47(3):261-5. PubMed ID: 823561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross tolerance to antinociception elicited by intracerebroventricular administration of mescaline and morphine to rabbits, and EEG correlates.
    Ferri S; Santagostino A; Braga PC
    Psychopharmacology (Berl); 1976 Jun; 47(3):267-9. PubMed ID: 823562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroencephalographic studies on the development of tolerance and cross tolerance to mescaline in the rat.
    Colasanti B; Khazan N
    Psychopharmacologia; 1975 Sep; 43(3):201-5. PubMed ID: 171694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Hydroxydopamine inhibits some effects of mescaline centrally administered to rabbits.
    Ferri S; Reina RA; Braga P
    Psychopharmacology (Berl); 1977 Dec; 55(2):147-9. PubMed ID: 414273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mescaline, 3,4-dimethoxyphenylethylamine, and adrenaline: sites of electroencephalographic arousal.
    Takeo Y; Himwich HE
    Science; 1965 Dec; 150(3701):1309-10. PubMed ID: 5856999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and behavioral components of tolerance to LSD and mescaline in rats.
    Murray TF; Craigmill AL; Fischer GJ
    Pharmacol Biochem Behav; 1977 Sep; 7(3):239-44. PubMed ID: 928480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new view of the structural relationship between LSD and mescaline.
    Nichols DE; Pfister WR; Yim GK; Cosgrove RJ
    Brain Res Bull; 1977; 2(3):169-71. PubMed ID: 890502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mescaline: no tolerance to excitatory effects.
    Bridger WH; Mandel IJ; Stoff DM
    Biol Psychiatry; 1973 Oct; 7(2):129-38. PubMed ID: 4748845
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the antinociceptive activity of intraventricularly administered acetylcholine to narcotic antinociception.
    Pedigo NW; Dewey WL
    Neurosci Lett; 1981 Oct; 26(1):85-90. PubMed ID: 7290542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central antagonism of tyramine-induced systemic hypotension by mescaline.
    Strahlendorf JR; Goldstein FJ
    J Pharm Pharmacol; 1977 Nov; 29(11):699-700. PubMed ID: 22607
    [No Abstract]   [Full Text] [Related]  

  • 11. Mescaline: a pharmacological profile.
    Aboul-Enein HY
    Am J Pharm Sci Support Public Health; 1973; 145(4):125-8. PubMed ID: 4742378
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationship studies on mescaline. II. Tolerance and cross-tolerance between mescaline and its analogues in the rat.
    Smythies JR; Sykes EA; Lord CP
    Psychopharmacologia; 1966; 9(5):434-46. PubMed ID: 5998418
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intraventricular injection of morphine and beta-endorphin on serotonin release from the spinal cord in rats.
    Jung JS; Song DK; Suh HW; Kim YH
    Pharmacol Biochem Behav; 1994 Dec; 49(4):1037-42. PubMed ID: 7533910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.
    FREEDMAN DX; AGHAJANIAN GK; ORNITZ EM
    Science; 1958 May; 127(3307):1173-4. PubMed ID: 13555858
    [No Abstract]   [Full Text] [Related]  

  • 15. The intracerebroventricular (ICV) administration of W-7, a calmodulin inhibitor, attenuates the development of morphine tolerance in rats.
    Sepehri G; Sheibani V; Azarang A; Shamsizadeh A; Afarinesh MR; Azizollahi S; Sepehri E
    Pak J Pharm Sci; 2010 Apr; 23(2):170-4. PubMed ID: 20363694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats.
    Hong O; Young GA; Khazan N
    Neuropharmacology; 1988 Aug; 27(8):807-12. PubMed ID: 2905786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance development to the arousal effects of nicotine.
    Hubbard JE; Gohd RS
    Pharmacol Biochem Behav; 1975; 3(3):471-6. PubMed ID: 1153451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mescaline and its derivative N-[3,4,5-trimethoxyphenylethyl]-aziridine on the spatial orientation of rats in a T-maze.
    Koupilová M; Herink J
    Physiol Bohemoslov; 1989; 38(6):497-502. PubMed ID: 2534189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.